# Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section

> **NCT05084599** · PHASE4 · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 124 (actual)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** Metaraminol 2.7μg/kg/min
- **DRUG:** Metaraminol 2μg/kg/min

## Key facts

- **NCT ID:** NCT05084599
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-12
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084599, "Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05084599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*